Management of high-grade stage I adenocarcinoma of the endometrium: hysterectomy following low dose external beam pelvic irradiation
Sixty-eight patients with FIGO stage I, grade 2 or 3 adenocarcinoma of the endometrium were treated according to a protocol involving 10 Gy external pelvic irradiation, prompt hysterectomy with surgical staging, and postoperative therapy individualized according to surgical-pathologic findings. Five-year survival for the entire group was 78%, 87% for those with grade 2 disease, and 59% for those with grade 3 disease. For patients whose disease was found to be confined to the uterus, surgical stage I, the 5-year survival was 98%. Patients with surgical stage I, grades 2 and 3 disease had 97 and 100% probabilities of surviving 5 years, respectively. Five-year disease-free probability was 96% for all patients with surgical stage I carcinoma, 97% for patients with grade 2 disease, and 94% for patients with grade 3 disease. Myometrial penetration influenced survival; no patient with less than 50% myometrial penetration died or suffered a relapse, while only 40% of patients with deeper penetration survived 5 years. Twenty-three percent of patients with surgically confirmed disease spread beyond the corpus survived 5 years; 29% remained disease-free at this interval. Ten of the 68 patients developed recurrences, none has had a known pelvic recurrence. Two major complications, one requiring surgery, were seen, both in patients receiving postoperative external beam irradiation. The rationale behind low-dose, preoperative external pelvic irradiation is described, and an approach to high-grade, FIGO stage I adenocarcinoma of the endometrium is outlined.
- Research Organization:
- Massachusetts General Hospital, Boston
- OSTI ID:
- 5730880
- Journal Information:
- Gynecol. Oncol.; (United States), Vol. 2
- Country of Publication:
- United States
- Language:
- English
Similar Records
Intravaginal brachytherapy alone for intermediate-risk endometrial cancer
Management of stage II endometrial adenocarcinoma
Related Subjects
62 RADIOLOGY AND NUCLEAR MEDICINE
CARCINOMAS
RADIOTHERAPY
SIDE EFFECTS
CONNECTIVE TISSUE
ION BEAMS
PATIENTS
SURGERY
SURVIVAL TIME
WOMEN
ANIMAL TISSUES
ANIMALS
BEAMS
BODY
DISEASES
FEMALES
MAMMALS
MAN
MEDICINE
NEOPLASMS
NUCLEAR MEDICINE
PRIMATES
RADIOLOGY
THERAPY
TISSUES
VERTEBRATES
560151* - Radiation Effects on Animals- Man
550603 - Medicine- External Radiation in Therapy- (1980-)